| MEDIGENE Medigene AG
88302793 15 Feb 2019 | on 28 Feb 2023
| Services in the field of molecular biology, namely, research and devel... Class 042 Class 042 Computer & Software Services & Scientific Services Services in the field of molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds and tumor antigens with pharmaceutical properties; development of test methods and test kits in the field of molecular biology; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumor therapy; development of tumor markers; development of diagnostic and therapeutic antibodies; genetic and biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific purposes | | | RHUDEX Medigene AG
88245830 31 Dec 2018 | on 23 Jul 2019
| Biotechnology services, namely, the development of T-cell receptor pha... Class 005 Class 005 Pharmaceutical Products Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases Class 010 Class 010 Medical Instrument Products Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes Class 042 Computer & Software Services & Scientific Services Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology | | | MEDIGENE Medigene AG
88347854 20 Mar 2019 | on 11 Apr 2022 | Services in molecular biology, in particular research and development ... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. Class 042 Class 042 Computer & Software Services & Scientific Services Cell analyses in the nature of medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto; Individualized medicine in the nature of medical services; medical services specifically, development of treatment plans for the treatment of tumors and/or neoplastic diseases, hematopoietic tumors, solid tumors; physical therapy adapted for individual patients Class 044 Medical, Beauty & Agricultural Services Services in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development of cellular tumour therapy; Development of tumour markers; Development of diagnostic and therapeutic antibodies | | | MEDIGENE MEDIGENE AG
75039069 02 Jan 1996 | on 26 Sep 2021 | medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ]... Class 005 Class 005 Pharmaceutical Products IN THE STATEMENT, COLUMN 1, BEFORE LINE 1, MEDIGENE AG, (GERMANY CORPORATION), MARTINSRIED, MUNICH, GERMANY, BY CHANGE OF NAME FROM, SHOULD BE INSERTED. Class 042 Class 042 Computer & Software Services & Scientific Services medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as vaccines against cancer and infectious diseases; test kits containing antibodies, enzymes, DNA and biochemical solutions for the testing of cardiac diseases, such as congestive heart failure, and cancer diseases, such as cervical and ovarian cancer, melanoma and other epithelial tumors in human beings and animals; diagnostic and therapeutic reagents, such as antibodies, DNA, enzymes and biochemical solutions for clinical medical laboratory use in the field of human and veterinary molecular biology, genetic engineering and bioengineering] | | | MEDIGENE MediGene AG
79043515 27 Apr 2007 | on 26 Feb 2021 | Medicines for humans and animals, except venous-therapeutics, namely, ... Class 005 Class 005 Pharmaceutical Products Medicines for humans and animals, except venous-therapeutics, namely, medicines for treating [ cardiovascular and vascular diseases, ] dermatological disorders and diseases, [ precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases, vaccines for treating cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; serums, namely, immune serums for passive vaccination for treating infectious diseases, diagnostic test kits comprising antibodies, antibody fragments, serums, soluble monoclonal T-cell receptors, peptides, peptide-analogues, enzymes, liposomes, dyes, radioactively labeled substances, for the purpose of testing, diagnosing and monitoring cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; proteins, proteinconjugates, peptides, enzymes and enzyme-preparations, antibodies, T-cell-proteins, attenuated viruses, virus-like particles, liposomes, ] herbal extracts, components of low molecular weight, all for use as medicines [, vaccines and parts of medical diagnostic test kits for treating, testing, diagnosing and monitoring all diseases mentioned above ] | | | AVIMOTIN MediGene AG
79068993 28 Apr 2009 | on 28 Apr 2019 | pharmaceutical preparations for the prevention, treatment and diagnosi... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes | | | YAMOKIN MediGene AG
79067273 26 Feb 2009 | on 26 Feb 2019 | pharmaceutical preparations for the prevention, treatment and diagnosi... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes | | | YOSITAN MediGene AG
79064735 23 Dec 2008 | on 23 Dec 2018 | pharmaceutical preparations for the prevention, treatment and diagnosi... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes | | | YOLAMIN MediGene AG
79064736 23 Dec 2008 | on 23 Dec 2018 | pharmaceutical preparations for the prevention, treatment and diagnosi... Class 005 Class 005 Pharmaceutical Products The following statement "all aforementioned goods for human use only" should be inserted at end of the class. | | | YUROXAN MediGene AG
77942356 23 Feb 2010 | on 25 May 2018 | Pharmaceutical and veterinary preparations for humans and animals, nam... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and veterinary preparations for humans and animals, namely, medicines, vaccines, and serums for diagnostics, testing, prevention, treatment, and therapeutics, in particular medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, in particular autoimmune diseases in particular rheumatic disorders, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematodes, rheumatoid arthritis, polyarthritis, Crohn's disease, and multiple sclerosis; medicines for treating skin diseases, in particular acne, actinic keratosis, alopecia, atopic dermatitis, Bowen's disease, cutaneous atopy, cutaneous T-cell lymphoma, Darrier's disease, Dartroud diathesis, dermatitis, eczema, genital herpes, genital warts, herpes, hyperkeratosis, hyperpigmentation, hyperplasia of the epidermis, hypopigmentation, ichthyosis, increased proliferation of skin cells, keloids, lentigo, lichen planus, melasma, molluscum contagiosum, mycosis fungoides, neoplasias, neurodermitis, pigmentation disorders, porokeratosis of Mibelli, psoriasis, removal of tattoos, rosacea, seborrhea, seborrheic keratosis, shingles, skin diseases related to inflammatory processes of skin cells, skin ulcers, vitiligo, warts, xerosis; medicines for treating tumourous diseases, in particular Astrocytomas, basal cell carcinomas, biliary cancers, bladder cancers, bone cancers, brain cancers, breast cancers, carcinomas, cervical cancers, cervical intraepithelial neoplasias, colorectal cancers, endocrine system cancers, ependymomas, epidermoid carcinomas, fibrosarcomas, gastric cancers, gastrointestinal cancers, glioblastomas, gynecologic cancers, head and neck cancers, hemangiomas, hepatomas, Hodgkin's lymphomas, Leukemia, liver cancers, lung cancers, lymphomas, medulloblastomas, meningiomas, mesothelaiomas, metastases, myelomas, neoplasias, neurectodermal cancers, neuroblastomas, neurofibromas, neurofibrosarcomas, neuronal cancers, non-Hodgkin's lymphomas, oligodendrogliomas, ovarian carcinoma, pancreatic cancers, pediatric cancers, penile cancer, pituitary adenomas, pleural cancers, renal cancer, sarcomas, Schwannomas, skin cancers, sqamous cell carcinomas, testicular cancers, thyroid cancers, thyroid tumors, urinary tract cancers, carcinoma of the prostate, melanoma, Kaposi's sarcoma, hepatocellular carcinoma; ALL OF THE ABOVE CONSISTING OF low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts | |